XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive Income (loss)
Non- controlling interests
Treasury shares
Total
Balance at Dec. 31, 2021 $ 88,849 $ 14,101,689 $ 241,946,362 $ 1,230,511 $ (122,498,259) $ 2,489,017 $ 7,593,014 $ (4,066,610) $ 140,884,573
Balance (in Shares) at Dec. 31, 2021 88,849,222             (144,206)  
Net Income (loss)   444,453 236,050 680,503
Share-based compensation for employee and director stock awards   34,779 34,779
Foreign currency translation adjustment   391,184 41,009 432,193
Balance at Mar. 31, 2022 $ 88,849 14,101,689 241,981,141 1,230,511 (122,053,806) 2,880,201 7,870,073 $ (4,066,610) 142,032,048
Balance (in Shares) at Mar. 31, 2022 88,849,222             (144,206)  
Balance at Dec. 31, 2022 $ 89,135 14,101,689 246,240,998 1,230,511 (131,946,705) (8,153,644) 6,883,123 $ (4,066,610) 124,378,497
Balance (in Shares) at Dec. 31, 2022 89,135,064             (144,206)  
Net Income (loss)   (1,380,355) (824,127) (2,204,482)
Share-based compensation for employee and director stock awards 4,897   4,897
Share-based compensation for employee and director stock awards (in Shares)                
Common stock issued to employees for stock award $ 16   (16)  
Common stock issued to employees for stock award (in Shares) 16,667                
Foreign currency translation adjustment   654,673 94,106 748,779
Balance at Mar. 31, 2023 $ 89,151 $ 14,101,689 $ 246,245,879 $ 1,230,511 $ (133,327,060) $ (7,498,971) $ 6,153,102 $ (4,066,610) $ 122,927,691
Balance (in Shares) at Mar. 31, 2023 89,151,731             (144,206)